BioSpace News Archive

Bionomics Limited announced that the U.S. Food and Drug Administration has granted Fast Track designation to the BNC210 development program for the treatment of Post-Traumatic Stress Disorder and other trauma-related and stressor-related disorders..

MediPharm Labs Corp. a global leader in specialized, research-driven cannabis extraction, distillation and purification, is pleased to announce Robert Kwon will join MediPharm Labs as Chief Financial Officer, effective November 18, 2019.

Rockwell Medical, Inc. announced that the Company will release its 2019 third quarter financial results on Monday, November 11, 2019, after the close of the U.S. financial markets.

Prescription-strength CelleRx to gently clean skin and ease post-procedure discomfort is now available without a prescription at www.CelleRx.com

Tonix Pharmaceuticals Holding Corp. announced that in the currently-enrolling Phase 3 study of Tonmya®* for the treatment of posttraumatic stress disorder, the timing of the primary endpoint analysis has been changed from Week 4 to Week 12 and the Company plans to add an interim analysis that allows for a potential sample size adjustment, based on guidance from its recent Breakthrough Therapy Type B Clinical Guidance meeting with the U.S. Food and Drug Administration.

BioCryst Pharmaceuticals, Inc. announced that the compensation committee of BioCryst’s board of directors granted five newly-hired employees options to purchase an aggregate of 217,500 shares of BioCryst common stock on October 31, 2019 as inducements material to each employee entering into employment with BioCryst.

CareDx, Inc., a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announces the launch of AlloSure 3.0, the next iteration in continued transplant patient-focused improvements.

Evolus, Inc., a performance beauty company with a customer-centric approach focused on delivering breakthrough products, provides a business update and reports financial results for the third quarter ended September 30, 2019.

Pluristem Therapeutics Inc., a leading regenerative medicine company developing novel placenta-based cell therapy products, announced that the RESTORE Consortium is hosting its 1st Advanced Therapies Science Meeting, which is being held November 25-26, 2019 in Berlin.

Bausch Health Companies Inc. announced its third-quarter 2019 financial results.